Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

McGAW SALE AGREEMENT CALLS FOR KENDALL TO PAY $120 MIL

Executive Summary

McGAW SALE AGREEMENT CALLS FOR KENDALL TO PAY $120 MIL. in cash "plus transfer the assets of two Kendall subsidiaries" -- NDM and Anatros -- to American Hospital Supply, American announced Nov. 13. NDM manufactures electrodes and grounding devices used in diagnostic equipment, while Anatros manufactures infusion devices. The definitive agreement is expected to be completed by Nov. 26. American Hospital Supply has had a long-term interest in NDM. In the late 1970s, American reportedly made acquisition overtures, only to lose out to Colgate in 1978. At the time, American's distribution accounted for approximately 98% of NDM's medical sales. In other divestiture moves, American reached a definitive agreement to sell its Haemonetics division to Latham Labs, a Massachusetts firm owned in part by the current Haemonetics management. American reported that it "has also received bids to purchase its Tucson glove plant, and believes it can reach a satisfactory agreement prior to the close of the ]Baxter[ merger." The Justice Department has informed American and Baxter that if definitive agreements are in place, it will consider permitting the merger to close even if the sales of McGaw, Haemonetics and the glove plant are not yet consummated. In that event, American said, "the two companies would agree to a consent decree requiring the prompt completion of the divestitures."
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS009261

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel